JP2002505100A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002505100A5 JP2002505100A5 JP2000534632A JP2000534632A JP2002505100A5 JP 2002505100 A5 JP2002505100 A5 JP 2002505100A5 JP 2000534632 A JP2000534632 A JP 2000534632A JP 2000534632 A JP2000534632 A JP 2000534632A JP 2002505100 A5 JP2002505100 A5 JP 2002505100A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- human
- embryonic
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cells Anatomy 0.000 description 82
- 210000000287 oocyte Anatomy 0.000 description 10
- 210000002950 fibroblast Anatomy 0.000 description 7
- 230000004069 differentiation Effects 0.000 description 6
- 102000016736 Cyclins Human genes 0.000 description 5
- 108050006400 Cyclins Proteins 0.000 description 5
- 210000004962 mammalian cells Anatomy 0.000 description 5
- 206010059512 Apoptosis Diseases 0.000 description 4
- -1 Bcl-w Proteins 0.000 description 4
- 102000006601 Thymidine Kinase Human genes 0.000 description 4
- 108020004440 Thymidine Kinase Proteins 0.000 description 4
- 230000006907 apoptotic process Effects 0.000 description 4
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 4
- 230000001809 detectable Effects 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 230000001225 therapeutic Effects 0.000 description 4
- 101710041887 vBCL2 Proteins 0.000 description 4
- 210000003958 Hematopoietic Stem Cells Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 101710032374 BCL2L1 Proteins 0.000 description 2
- 102100015655 BCL2L1 Human genes 0.000 description 2
- 102100007320 BNIP3 Human genes 0.000 description 2
- 101700007682 BNIP3 Proteins 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 210000003855 Cell Nucleus Anatomy 0.000 description 2
- 101710029818 DA18 Proteins 0.000 description 2
- 101700045225 DHX9 Proteins 0.000 description 2
- 102100017780 DHX9 Human genes 0.000 description 2
- 101700057458 Drice Proteins 0.000 description 2
- 101710012545 E1B Proteins 0.000 description 2
- 210000003981 Ectoderm Anatomy 0.000 description 2
- 210000001900 Endoderm Anatomy 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 101700002184 GATA4 Proteins 0.000 description 2
- 101700059151 HNF4A Proteins 0.000 description 2
- 210000002510 Keratinocytes Anatomy 0.000 description 2
- 101710025233 LLGL1 Proteins 0.000 description 2
- 101700031439 MCL1 Proteins 0.000 description 2
- 102100002383 MCL1 Human genes 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 210000003716 Mesoderm Anatomy 0.000 description 2
- 101710040019 ORF16 Proteins 0.000 description 2
- 241000283898 Ovis Species 0.000 description 2
- 206010061536 Parkinson's disease Diseases 0.000 description 2
- 241000288906 Primates Species 0.000 description 2
- 101710028925 RP016 Proteins 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 101700074015 VPP Proteins 0.000 description 2
- 102100006622 VPS26A Human genes 0.000 description 2
- 101710012303 VPS26A Proteins 0.000 description 2
- 101700030690 YO02 Proteins 0.000 description 2
- 230000003213 activating Effects 0.000 description 2
- 230000001058 adult Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 101700069648 ced-9 Proteins 0.000 description 2
- 230000007159 enucleation Effects 0.000 description 2
- 210000002919 epithelial cells Anatomy 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 102000006495 integrins Human genes 0.000 description 2
- 108010044426 integrins Proteins 0.000 description 2
- 101700053671 manC Proteins 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 210000002569 neurons Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 101710027505 ywlE Proteins 0.000 description 2
- 206010000565 Acquired immunodeficiency syndrome Diseases 0.000 description 1
- 206010001897 Alzheimer's disease Diseases 0.000 description 1
- 206010002026 Amyotrophic lateral sclerosis Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010007709 Cartilage disease Diseases 0.000 description 1
- 206010007710 Cartilage injury Diseases 0.000 description 1
- 210000001612 Chondrocytes Anatomy 0.000 description 1
- 206010012601 Diabetes mellitus Diseases 0.000 description 1
- 210000001161 Embryo, Mammalian Anatomy 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- IRSCQMHQWWYFCW-UHFFFAOYSA-N Ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
- 229960002963 Ganciclovir Drugs 0.000 description 1
- 210000003494 Hepatocytes Anatomy 0.000 description 1
- 201000001971 Huntington's disease Diseases 0.000 description 1
- 208000005230 Leg Ulcer Diseases 0.000 description 1
- 210000002751 Lymph Anatomy 0.000 description 1
- 210000004698 Lymphocytes Anatomy 0.000 description 1
- 208000003627 Muscular Dystrophy Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 210000004927 Skin cells Anatomy 0.000 description 1
- 206010040943 Skin ulcer Diseases 0.000 description 1
- 208000008513 Spinal Cord Injury Diseases 0.000 description 1
- 206010061367 Spinal cord disease Diseases 0.000 description 1
- 206010046566 Urinary tract disease Diseases 0.000 description 1
- 208000000207 Urologic Disease Diseases 0.000 description 1
- 201000003883 cystic fibrosis Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 201000010238 heart disease Diseases 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 230000000968 intestinal Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 201000009673 liver disease Diseases 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 210000000663 muscle cells Anatomy 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 210000003061 neural cell Anatomy 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 230000002485 urinary Effects 0.000 description 1
- 201000001923 urinary system disease Diseases 0.000 description 1
- 201000011528 vascular disease Diseases 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3294598A | 1998-03-02 | 1998-03-02 | |
| US09/032,945 | 1998-03-02 | ||
| PCT/US1999/004608 WO1999045100A1 (en) | 1998-03-02 | 1999-03-02 | Embryonic or stem-like cell lines produced by cross-species nuclear transplantation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002505100A JP2002505100A (ja) | 2002-02-19 |
| JP2002505100A5 true JP2002505100A5 (xx) | 2006-06-15 |
Family
ID=21867727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000534632A Pending JP2002505100A (ja) | 1998-03-02 | 1999-03-02 | 種間核移植によって作製された胚性または幹細胞様細胞株 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1060243A4 (xx) |
| JP (1) | JP2002505100A (xx) |
| CN (1) | CN1299408A (xx) |
| AU (1) | AU759322B2 (xx) |
| BR (1) | BR9908499A (xx) |
| CA (1) | CA2323094A1 (xx) |
| IL (1) | IL138201A0 (xx) |
| NZ (1) | NZ506808A (xx) |
| WO (1) | WO1999045100A1 (xx) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA02002744A (es) * | 1999-09-14 | 2003-07-21 | Univ Massachusetts | Lineas de celulas embrionarias o tipo celulas madre y metodos para mejorar el desarrollo embrionario. |
| BR0014864A (pt) * | 1999-10-15 | 2002-11-19 | Advanced Cell Tech Inc | Métodos de produzir células progenitoras diferenciadas e células tronco embriÈnicas defeituosas em linhagem |
| MXPA02006093A (es) * | 1999-12-20 | 2004-08-23 | Univ Massachusetts | Celulas tipo madre o embrionicas producidas por transplante nuclear de especies de cruza. |
| US6921665B2 (en) | 2000-11-27 | 2005-07-26 | Roslin Institute (Edinburgh) | Selective antibody targeting of undifferentiated stem cells |
| US6576464B2 (en) * | 2000-11-27 | 2003-06-10 | Geron Corporation | Methods for providing differentiated stem cells |
| WO2002062131A2 (en) * | 2001-02-02 | 2002-08-15 | Infigen, Inc. | Method of cloning transgenic mammalian animals using pseudonuclei |
| CN1558949A (zh) * | 2001-11-06 | 2004-12-29 | �Ϻ��ڶ�ҽ�ƴ�ѧ | 利用兔卵母细胞制备体细胞胚胎 |
| HUP0501094A2 (en) | 2001-11-06 | 2006-04-28 | Univ Shanghai 2Nd Medical | Somatic cell derived embryonic stem cells and its differentiated cells |
| AU2003230725A1 (en) * | 2002-04-01 | 2003-10-20 | Gtc Biotherapeutics, Inc. | A method for selecting cell lines to be used for nuclear transfer in mammalian species |
| WO2013010045A1 (en) | 2011-07-12 | 2013-01-17 | Biotime Inc. | Novel methods and formulations for orthopedic cell therapy |
| WO2013177228A1 (en) * | 2012-05-22 | 2013-11-28 | Loma Linda University | Generation of integration/transgene-free stem cells |
| EP3712254A1 (en) * | 2014-05-28 | 2020-09-23 | Children's Hospital Medical Center | Methods and systems for converting precursor cells into gastric tissues through directed differentiation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5905042A (en) * | 1996-04-01 | 1999-05-18 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Cultured inner cell mass cell lines derived from bovine or porcine embryos |
| EP0934403A4 (en) * | 1996-08-19 | 2001-03-14 | Univ Massachusetts | ROWS OF EMBRYONIC OR STRAIN-LIKE CELLS PRODUCED BY CROSS NUCLEAR TRANSPLANTATION OF SPECIES |
| NZ337495A (en) * | 1997-03-06 | 2001-06-29 | Infigen Inc | Bovine primordial germ cells and their use in cloning |
| AU8587598A (en) * | 1997-07-26 | 1999-02-16 | Wisconsin Alumni Research Foundation | Trans-species nuclear transfer |
-
1999
- 1999-03-02 CN CN99805691A patent/CN1299408A/zh active Pending
- 1999-03-02 BR BR9908499-6A patent/BR9908499A/pt not_active Application Discontinuation
- 1999-03-02 EP EP99911062A patent/EP1060243A4/en not_active Withdrawn
- 1999-03-02 NZ NZ506808A patent/NZ506808A/en unknown
- 1999-03-02 WO PCT/US1999/004608 patent/WO1999045100A1/en active IP Right Grant
- 1999-03-02 AU AU29795/99A patent/AU759322B2/en not_active Ceased
- 1999-03-02 CA CA002323094A patent/CA2323094A1/en not_active Abandoned
- 1999-03-02 JP JP2000534632A patent/JP2002505100A/ja active Pending
- 1999-03-02 IL IL13820199A patent/IL138201A0/xx not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tian et al. | Cloning animals by somatic cell nuclear transfer–biological factors | |
| Inoue et al. | Development of new inbred transgenic strains of rats with LacZ or GFP | |
| US20060240556A1 (en) | Use of RNA interference for the creation of lineage specific ES and other undifferentiated cells and production of differentiated cells in vitro by co-culture | |
| AU740709B2 (en) | Embryonic or stem-like cell lines produced by cross species nuclear transplanta tion | |
| US20060247195A1 (en) | Method of altering cell properties by administering rna | |
| JP2003503071A (ja) | 脱分化レシピエント細胞への細胞質移入 | |
| JP2001509362A5 (xx) | ||
| Chojnacka-Puchta et al. | CRISPR/Cas9 gene editing in a chicken model: current approaches and applications | |
| JP2002537803A (ja) | 異種間核移植により産生される胚性細胞株あるいは幹様細胞株 | |
| JP2001509361A (ja) | 分化した無血清飢餓細胞からの供与核を用いるクローニング | |
| JP2002505100A5 (xx) | ||
| JP2003508079A (ja) | 老年期体細胞からクローン化された動物中の細胞寿命のテロメア回復と延長 | |
| Kawarasaki et al. | Profile of new green fluorescent protein transgenic Jinhua pigs as an imaging source | |
| US20040072343A1 (en) | Cell reprogramming | |
| CN1299408A (zh) | 通过异种间的核移植产生的胚细胞或干细胞样细胞系 | |
| Skrzyszowska et al. | Generation of transgenic rabbits by the novel technique of chimeric somatic cell cloning | |
| US20040040050A1 (en) | Production of agricultural animals from embryonic stem (es) cells | |
| JP2004500038A (ja) | 選択したドナー細胞を用いる核移植 | |
| Woessner | The Evolution of Patents on Life-Transgenic Animals, Clones and Stem Cells | |
| KR20200132740A (ko) | 요산분해효소를 과발현하는 줄기세포를 유효성분으로 포함하는 통풍의 예방 또는 치료용 조성물 | |
| JP2005523685A (ja) | 体細胞由来胚幹細胞及びそれらの分化子孫 | |
| JP2006522609A (ja) | 動物の体細胞核移植と関係する紡錘体欠損を修正するための方法 | |
| JP4321936B2 (ja) | 不死化血管周皮細胞株 | |
| WO2023143637A1 (zh) | 一种实用型类脑微器官的构建与应用 | |
| JP2003530848A (ja) | 同種異系の核及びミトコンドリアを含む多能細胞 |